CC
Corton Capital Portfolio holdings
AUM
$85.9M
1-Year Return
50.75%
This Quarter Return
+19.06%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$174M
AUM Growth
-$31.4M
(-15%)
Cap. Flow
-$52.9M
Cap. Flow
% of AUM
-30.34%
Top 10 Holdings %
Top 10 Hldgs %
48.99%
Holding
691
New
222
Increased
56
Reduced
93
Closed
319
Top Buys
| 1 |
Palantir
PLTR
|
$635K |
| 2 |
Progressive
PGR
|
$585K |
| 3 |
Applied Materials
AMAT
|
$522K |
| 4 |
United Natural Foods
UNFI
|
$521K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$515K |
Top Sells
| 1 |
IGMS
IGM Biosciences
IGMS
|
$1.1M |
| 2 |
Root
ROOT
|
$1.03M |
| 3 |
CareDx
CDNA
|
$929K |
| 4 |
Entrada Therapeutics
TRDA
|
$924K |
| 5 |
Southern Company
SO
|
$883K |
Sector Composition
| 1 | Technology | 56.1% |
| 2 | Healthcare | 9.35% |
| 3 | Financials | 7.08% |
| 4 | Industrials | 6.17% |
| 5 | Consumer Discretionary | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Global E Online
GLBE
$5.95B
| $253K | 0.15% |
+4,639
| New | +$253K |
|
177
Adient
ADNT
$1.99B
| $253K | 0.15% |
14,672
+485
| +3% | +$8.36K |
|
178
Jakks Pacific
JAKK
$198M
| $252K | 0.14% |
8,949
-22,157
| -71% | -$624K |
|
179
Option Care Health
OPCH
$4.67B
| $251K | 0.14% |
+10,806
| New | +$251K |
|
180
Automatic Data Processing
ADP
$122B
| $251K | 0.14% |
856
-871
| -50% | -$255K |
|
181
Marcus Corp
MCS
$479M
| $249K | 0.14% |
+11,588
| New | +$249K |
|
182
Donegal Group Class A
DGICA
$711M
| $249K | 0.14% |
16,101
+1,108
| +7% | +$17.1K |
|
183
Scholar Rock
SRRK
$3.12B
| $249K | 0.14% |
5,759
-9,075
| -61% | -$392K |
|
184
Alcoa
AA
$8.1B
| $248K | 0.14% |
6,576
-1,427
| -18% | -$53.9K |
|
185
Skillsoft
SKIL
$131M
| $248K | 0.14% |
10,365
-16,528
| -61% | -$396K |
|
186
Capital Bancorp
CBNK
$577M
| $247K | 0.14% |
+8,682
| New | +$247K |
|
187
Light & Wonder
LNW
$7.37B
| $245K | 0.14% |
+2,833
| New | +$245K |
|
188
General Dynamics
GD
$86.7B
| $244K | 0.14% |
+927
| New | +$244K |
|
189
Viridian Therapeutics
VRDN
$1.52B
| $243K | 0.14% |
12,702
-3,103
| -20% | -$59.5K |
|
190
Laureate Education
LAUR
$4.08B
| $243K | 0.14% |
+13,297
| New | +$243K |
|
191
BioCryst Pharmaceuticals
BCRX
$1.74B
| $243K | 0.14% |
32,337
-7,154
| -18% | -$53.8K |
|
192
Boston Scientific
BSX
$159B
| $243K | 0.14% |
2,718
-678
| -20% | -$60.6K |
|
193
Rocky Brands
RCKY
$223M
| $243K | 0.14% |
+10,645
| New | +$243K |
|
194
Apellis Pharmaceuticals
APLS
$3.62B
| $242K | 0.14% |
7,595
-636
| -8% | -$20.3K |
|
195
Arteris
AIP
$377M
| $242K | 0.14% |
23,778
+7,430
| +45% | +$75.7K |
|
196
Ardelyx
ARDX
$1.58B
| $241K | 0.14% |
+47,540
| New | +$241K |
|
197
WD-40
WDFC
$2.93B
| $241K | 0.14% |
+993
| New | +$241K |
|
198
Trupanion
TRUP
$1.92B
| $240K | 0.14% |
4,983
-5,953
| -54% | -$287K |
|
199
Liquidity Services
LQDT
$841M
| $240K | 0.14% |
+7,432
| New | +$240K |
|
200
Pilgrim's Pride
PPC
$10.5B
| $239K | 0.14% |
+5,259
| New | +$239K |
|